Internal Medicine, Endocrinology, Diabetes, & Metabolism · Corvallis, OR
NPI
1841421229
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
3615 NW Samaritan Dr Ste G2
Corvallis, OR, 97330
Phone (541) 768-7900
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
539 services
Medicare patients, 2024
130
Average age 71
Drug cost, 2024
$492K
1,490 prescriptions
Company payments, 2025
$168
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tim Arakawa was code 99214 (office e&m - established), 133 times for 70 patients. In total Tim Arakawa billed 539 services in 11 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 133 | 70 | $61.16 | $8,134 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 131 | 77 | $11.56 | $1,514 |
| 95251 Test - Miscellaneous | Facility | 54 | 25 | $24.65 | $1,331 |
| 99215 Office E&M - Established | Facility | 54 | 35 | $95.66 | $5,166 |
| 99214 Office E&M - Established | Office | 49 | 28 | $80.12 | $3,926 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 45 | 27 | $10.78 | $485 |
| 99205 Office E&M - New | Facility | 17 | 17 | $132.82 | $2,258 |
| 99215 Office E&M - Established | Office | 12 | 11 | $89.06 | $1,069 |
By year: 2022 $24K for 356 services; 2023 $26K for 377 services; 2024 $26K for 539 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tim Arakawa prescribed most often to Medicare patients was Levothyroxine Sodium, with 319 prescriptions and refills. In total Tim Arakawa wrote 1,490 Medicare prescriptions that cost $492K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 319 | 772 | 70 | $4,764 |
| Jardiance Empagliflozin | 61 | 110 | 12 | $63K |
| Synthroid Levothyroxine Sodium | 59 | 124 | 12 | $3,610 |
| Methimazole Generic | 58 | 116 | 14 | $452 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 55 | 79 | Under 11 | $63K |
| Hydrocortisone Generic | 46 | 109 | 11 | $3,134 |
| Mounjaro Tirzepatide | 38 | 43 | Under 11 | $45K |
| Alendronate Sodium Generic | 37 | 91 | 12 | $383 |
| Tresiba Flextouch U-100 Insulin Degludec | 37 | 82 | 14 | $29K |
| Trulicity Dulaglutide | 34 | 34 | Under 11 | $33K |
| Metformin Hcl Er Metformin Hcl | 34 | 81 | 11 | $467 |
| Metformin Hcl Generic | 33 | 85 | Under 11 | $468 |
| Humalog Kwikpen U-100 Insulin Lispro | 31 | 49 | Under 11 | $9,081 |
| Novolog Flexpen Insulin Aspart | 29 | 38 | Under 11 | $7,720 |
| Tresiba Flextouch U-200 Insulin Degludec | 27 | 51 | Under 11 | $28K |
Brand drugs: 677 claims; generic drugs: 698 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tim Arakawa $168 ($168 in general payments such as food, travel and fees) from 7 companies. The largest payer was Medtronic, Inc. with $30.96.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.